Skip to content

Health Impact Investigation of Ionless (Hypochlorous Acid Water) Space Spraying

Health Impact Investigation of Ionless (Hypochlorous Acid Water) Space Spraying - Health Impact Investigation of Ionless (Hypochlorous Acid Water) Space Spraying

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061827
Enrollment
32
Registered
2026-06-08
Start date
2023-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse events (eye itching, eye redness, sore throat, runny nose, cough, odor of hypochlorous acid solution, stress caused by the sound of the nebulizer)

Interventions

Hypochlorous Acid Water Spray Group: Set the spray program settings on the CL Mist L humidifier manufactured by Nipro Corporation so that the effective chlorine concentration in the air reaches 0.02 p

Sponsors

Iwate Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study population consists of patients hospitalized at Uguisu-juku Onsen Hospital during the enrollment period who are capable of communicating, understand the study protocol, and have expressed a willingness to participate (proxy signing of the informed consent form is permitted). Patients must not exhibit any of the following symptoms: itchy eyes, red eyes, sore throat, runny nose, or cough.

Exclusion criteria

Exclusion criteria: Patients whom the principal investigator has determined to be unsuitable as study participants.

Design outcomes

Primary

MeasureTime frame
The observation items on the health observation sheet include itchy eyes, red eyes, sore throat, runny nose, cough, the odor of hypochlorous acid water, and stress caused by the sound of the nebulizer. Staff at the collaborating research institutions will determine the presence or absence of each symptom based on interviews with patients. Prior to the study, the principal investigator will brief the staff on the details of the observation items and confirm that patients are free of all symptoms listed before space spraying begins. The primary endpoint is to calculate the incidence rate of adverse events from the health observation sheet and to assess safety based on that rate.

Countries

Japan

Contacts

Public ContactMikio TAKAHASHI

Iwate Medical University Department of General Practice

mitakaha@iwate-med.ac.jp019-613-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026